nach oben

Journal of Neurology

Erschienen in:

01.09.2014 | Original Communication

Smoking and multiple sclerosis: evidence for latitudinal and temporal variation

verfasst von: C. O’Gorman, S. A. Broadley

Erschienen in: Journal of Neurology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

There is growing evidence for the role of smoking in the aetiology of multiple sclerosis. We have expanded existing meta-analyses and further explored the roles of study design, gender, latitude and year of study with regression modelling. We have found a consistent association between smoking and MS with an odds ratio of approximately 1.5, with males at higher risk. This finding is independent of study design. However, latitude and year of study may have unexpected influence. Smoking appeared to confer a greater risk to females living closer to the equator than to females at higher latitudes. The effect of cigarette smoke exposure on MS risk may not be fixed over time, but could be increasing. These results suggest a threshold model of MS risk that includes a fairly constant genetic risk (for Caucasian populations) together with variable environmental risks which are dominated by vitamin D deficiency at higher latitudes and are more significant in women who have an intrinsically lower threshold for development of disease.

Nur mit Berechtigung zugänglich

Antonovsky A, Leibowitz U, Smith HA, Medalie JM, Balogh M, Kats R, Halpern L, Alter M (1965) Epidemiologic study of MS in Israel. I. An overall review of methods and findings. Arch Neurol 13:183–193CrossRefPubMed

Birkett NJ (1997) Trends in smoking by birth cohort for births between 1940 and 1975: a reconstructed cohort analysis of the 1990 Ontario Health Survey. Prev Med 26:534–541CrossRefPubMed

Clayton D, Hills M (1993) Statistical methods in epidemiology. Oxford University Press, Oxford

Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517CrossRefPubMed

Dahl J, Myhr KM, Daltveit AK, Skjaerven R, Gilhus NE (2007) Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. Eur J Neurol: Off J Eur Fed Neurol Soc 14:1113–1117CrossRef

Deeks JJ, Altman DG (editors) (2011) Chapter 9: analysing data and undertaking meta-analyses. In: Higgins JPT GSe (ed) Cochrane handbook for systematic reviews of interventions the cochrane collaboration. Wiley

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

Egger M, Schneider M, Davey Smith G (1998) Spurious precision? Meta-analysis of observational studies. BMJ 316:140–144

Egger M, Smith GD (1995) Misleading meta-analysis. BMJ 311:753–754PubMedCentralCrossRefPubMed

10.

Escobedo LG, Peddicord JP (1996) Smoking prevalence in US birth cohorts: the influence of gender and education. Am J Public Health 86:231–236PubMedCentralCrossRefPubMed

11.

Forey B, Lee PN (2007) New edition of International Smoking Statistics. Int J Epidemiol 36:471–472CrossRefPubMed

12.

Graham NM (1990) The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev 12:149–178PubMed

13.

Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV (2011) Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 6:e16149PubMedCentralCrossRefPubMed

14.

Hawkes CH (2007) Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 13:610–615CrossRefPubMed

15.

Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L (2011) Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler 17:788–793CrossRefPubMed

16.

Hedstrom AK, Sundqvist E, Baarnhielm M, Nordin N, Hillert J, Kockum I, Olsson T, Alfredsson L (2011) Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain: J Neurol 134:653–664CrossRef

17.

Hernan MA, Olek MJ, Ascherio A (2001) Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154:69–74CrossRefPubMed

18.

Hoffmann D, Djordevic MV, Brunnemann KD (1996) Changes in cigarette design and composition over time and how they influence the yields of smoke constituents. In: The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of US cigarettes. US Department of Health and Human Services

19.

Holt PG (1987) Immune and inflammatory function in cigarette smokers. Thorax 42:241–249PubMedCentralCrossRefPubMed

20.

Jafari N, Hoppenbrouwers IA, Hop WC, Breteler MM, Hintzen RQ (2009) Cigarette smoking and risk of MS in multiplex families. Mult Scler 15:1363–1367CrossRefPubMed

21.

Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520–532CrossRefPubMed

22.

Kotzamani D, Panou T, Mastorodemos V, Tzagournissakis M, Nikolakaki H, Spanaki C, Plaitakis A (2012) Rising incidence of multiple sclerosis in females is associated with urbanization. Neurology 78:1728–1735CrossRefPubMed

23.

Maghzi AH, Etemadifar M, Heshmat-Ghahdarijani K, Moradi V, Nonahal S, Ghorbani A, Minagar A (2011) Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran. Neuroepidemiology 37:238–242CrossRefPubMed

24.

Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67:1488–1492CrossRefPubMed

25.

Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2009) High frequency of adverse health behaviors in multiple sclerosis. Mult Scler 15:105–113CrossRefPubMed

26.

Mikaeloff Y, Caridade G, Tardieu M, Suissa S, Group Ks (2007) Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain: J Neurol 130:2589–2595CrossRef

27.

Morabia A, Bernstein MS, Antonini S (2000) Smoking, dietary calcium and vitamin D deficiency in women: a population-based study. Eur J Clin Nutr 54:684–689CrossRefPubMed

28.

Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sorensen TI, Baker JL (2013) Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler 19:1323–1329PubMedCentralCrossRefPubMed

29.

O’Gorman C, Bukhari W, Todd A, Freeman S, Broadley S (2014) Smoking increases the risk of multiple sclerosis in Queensland, Australia. J Clin Neurosci (in press)

30.

O’Gorman C, Lin R, Stankovich J, Broadley SA (2013) Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology 40:1–12CrossRefPubMed

31.

O’Gorman C, Lucas R, Taylor B (2012) Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 13:11718–11752PubMedCentralCrossRefPubMed

32.

Orton S-M, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5:932–936CrossRefPubMed

33.

Ramagopalan SV, Lee JD, Yee IM, Guimond C, Traboulsee AL, Ebers GC, Sadovnick AD (2013) Association of smoking with risk of multiple sclerosis: a population-based study. J Neurol 260:1778–1781CrossRefPubMed

34.

Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton S-M, Dyment DA, DeLuca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC (2009) Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 5:e1000369PubMedCentralCrossRefPubMed

35.

Riise T, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmoy T, Kampman M, Landtblom A, Lauer K, Myhr K, et al. (2011) Negative interaction between smoking and infectious mononucleosis in the risk of MS. In: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis. Amsterdam, The Netherlands

36.

Ronneberg A, Lund KE, Hafstad A (1994) Lifetime smoking habits among Norwegian men and women born between 1890 and 1974. Int J Epidemiol 23:267–276CrossRefPubMed

37.

Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, Køber L, Jensen JE (2012) Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study. Eur J Endocrinol/Eur Fed Endocr Soc 167:553–560

38.

Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T, Sundström P, Ascherio A (2010) Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 74:1365–1371

39.

Simpson CA, Newell DJ, Schapira K (1966) Smoking and multiple sclerosis. Neurology 16:1041–1043CrossRefPubMed

40.

Sterne JAC, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046–1055CrossRefPubMed

41.

Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T (2012) Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis. Neurology 79:1363–1368CrossRefPubMed

42.

Sundstrom P, Nystrom L, Hallmans G (2008) Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol: Off J Eur Fed Neurol Soc 15:579–583CrossRef

43.

Team RC (2012) R: a language and environment for statistical computing. In: R foundation for statistical computing

44.

Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1–48

45.

White V (2003) How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001. Tob Control 12:67ii-74

Titel: Smoking and multiple sclerosis: evidence for latitudinal and temporal variation
verfasst von: C. O’Gorman
S. A. Broadley
Publikationsdatum: 01.09.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 9/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-014-7397-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2014

Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis

Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype in a patient with a novel heterozygous POLG mutation

Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis

Body mass index delineates ALS from FTD: implications for metabolic health